LogicBio Therapeutics, Inc. Shareholders' Equity
LogicBio Therapeutics, Inc. had Shareholders' Equity of $15.74 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-11-14
- 2022-09-30: Stockholders' Equity Attributable to Parent $15.74M.
- 2022-06-30: Stockholders' Equity Attributable to Parent $20.72M.
- 2022-03-31: Stockholders' Equity Attributable to Parent $24.91M.
- 2021-12-31: Stockholders' Equity Attributable to Parent $30.73M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2022-09-30 | $15.74M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $20.72M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $24.91M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $30.73M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $38.76M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $44.82M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $54.23M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $61.43M 10-K · filed 2022-03-04 |
| 2020-09-30 | $22.29M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $28.16M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $33.71M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $42.29M 10-K · filed 2021-03-15 |
| 2019-09-30 | $53.20M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $63.41M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $72.82M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $80.22M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$18.61M 10-Q · filed 2018-12-03 |
| 2017-12-31 | -$8.60M 10-K · filed 2019-04-01 |